Commentary

Podcast

Advancing the optimal diagnosis & treatment of thyroid eye disease

In this PER On Air Ophthalmology Times podcast, an expert panel discusses diagnosing TED and providing appropriate pharmacologic and surgical treatments.

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Thyroid eye disease is a condition frequently associated with Graves disease that involves both acute and chronic inflammation of the orbit. Patients may experience ocular discomfort, appearance changes, and vision loss. In this podcast, an expert panel discusses diagnosing TED and providing appropriate pharmacologic and surgical treatments. 

Wendy W. Lee, MD

Professor of Clinical Ophthalmology and Dermatology
Oculofacial Plastic & Reconstructive Surgery, Orbit and Oncology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine, Miami, FL

Chris R. Alabiad, MD

Assistant Dean for Student Affairs
Ophthalmology Residency Program Director
Professor of Clinical Ophthalmology
Oculofacial Plastic & Reconstructive Surgery and Orbital Oncology
Bascom Palmer Eye Institute/Miami Veterans Affairs Hospital
University of Miami Miller School of Medicine, Miami, FL

Katherine Rachon, OD, FAAO, Dipl ABO

Residency Director
Virginia Eye Consultants
Hampton, VA

Ana Carolina Victoria, MD, FACS

Oculofacial Plastic and Reconstructive Surgery
Center for Excellence in Eye Care
Miami, FL

Related Videos
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
(Image credit: Ophthalmology Times) AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhD
(Image credit: Ophthalmology Times) AGS 2025: Long-term efficacy and safety of standalone and phaco ELT with Marc Toeteberg-Harms, MD
(Image credit: Ophthalmology Times) Thomas W. Samuelson, MD, shares clinical perspectives on DSLT, SLT, and glaucoma management
Image credit: Ophthalmology Times; Angiogenesis 2025: Encapsulated cell therapy for MacTel shows long-term efficacy in phase 3 trials
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
Image credit: Ophthalmology Times; EnVision Summit 2025: Sonia H. Yoo, MD, shares what to expect from the cataract and refractive agenda
Related Content
(Image credit: StockAdobe/Andrija)
February 25th 2025

Australian Society of Ophthalmologists announces new board appointments

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

(Courtesy of Cleveland Clinic)
February 24th 2025

Cleveland Clinic’s Cole Eye Institute expands with Jeffrey and Patricia Cole Pavilion

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

(Image credit: AdobeStock/InsideCreativeHouse)
February 19th 2025

Alcon announces US launch of Voyager direct selective laser trabeculoplasty device

Shaping the future of retinal therapy
February 19th 2025

Shaping the future of retinal therapy

© 2025 MJH Life Sciences

All rights reserved.